Home » Topics » BioWorld Science

BioWorld Science
RSS

New bifunctional piperidinamide derivative as sigma-1 and mu-opioid receptor agonist

Dec. 9, 2021

Smart Immune collaborates with MSK to expand ProTcell pipeline

Dec. 9, 2021

Discovery of novel o-aminobenzamide derivative with promising activity in models of gastric cancer

Dec. 9, 2021

CP-COV03 with dexamethasone produces synergistic effect for severe COVID-19 in hamsters

Dec. 9, 2021

Codiak Biosciences tests exosome-based vaccine platform for SARS-CoV-2

Dec. 9, 2021

Dual BRD4 and ULK3 inhibition as novel therapeutic strategy for TNBC

Dec. 9, 2021

EZH2 methylation of p38 linked to breast cancer progression

Dec. 9, 2021

New Wnt signaling activators identified at Biosplice Therapeutics

Dec. 9, 2021

Edgewise Therapeutics patents myosin inhibitors

Dec. 9, 2021

New ENPP1 inhibitors discovered at Vir Biotechnology

Dec. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...